Updated Jul 16, 2026
Adsett Roger has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $20.55M.
Roger Adsett is the Chief Operating Officer at Insmed Inc, a biopharmaceutical company focused on developing treatments for serious and rare diseases. He has been involved in the company's operations and strategic initiatives, contributing to its mission of transforming patient lives.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | DFTX | Definium Therapeutics, Inc. | A — Grant or award | 3.6K | $0.00 | |
| 2026-06-05 | INSM | INSMED Inc | S — Open-market sale | 2.4K | $102.27 | $242K |
| 2026-05-15 | INSM | INSMED Inc | S — Open-market sale | 5.8K | $116.18 | $678K |
| 2026-04-03 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 62.3K | $164.95 | $10.28M |
| 2026-04-03 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 19.0K | $164.11 | $3.12M |
| 2026-04-03 | INSM | INSMED Inc | S — Open-market sale [10b5-1] | 6.7K | $163.18 | $1.10M |
| 2026-04-03 | INSM | INSMED Inc | M — Option exercise [10b5-1] | 88.1K | $14.56 | $1.28M |
| 2026-02-04 | INSM | INSMED Inc | S — Open-market sale | 791 | $156.17 | $124K |
| 2025-08-19 | INSM | INSMED Inc | S — Open-market sale | 4.8K | $128.27 | $617K |
| 2025-08-19 | INSM | INSMED Inc | S — Open-market sale | 20.2K | $127.42 | $2.57M |
| 2025-06-16 | INSM | INSMED Inc | S — Open-market sale | 4.2K | $99.32 | $416K |
| 2025-06-16 | INSM | INSMED Inc | S — Open-market sale | 6.5K | $98.50 | $640K |
| 2025-06-03 | INSM | INSMED Inc | S — Open-market sale | 1.9K | $71.50 | $133K |
| 2025-05-15 | INSM | INSMED Inc | A — Grant or award | 6.5K | $0.00 | |
| 2025-05-13 | INSM | INSMED Inc | S — Open-market sale | 1.9K | $65.61 | $126K |
| 2025-05-13 | INSM | INSMED Inc | S — Open-market sale | 7.5K | $67.81 | $507K |
Roger Adsett is the Chief Operating Officer at Insmed Inc, a biopharmaceutical company focused on developing treatments for serious and rare diseases. He has been involved in the company's operations and strategic initiatives, contributing to its mission of transforming patient lives.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 13 open-market sales ($20.55M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Adsett Roger profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.